Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Delcath Systems Inc (DCTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,855
  • Shares Outstanding, K 5,740
  • Annual Sales, $ 2,720 K
  • Annual Income, $ -45,120 K
  • 36-Month Beta -0.64
  • Price/Sales 2.22
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3,618.27
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9000 +0.07%
on 10/15/18
10.3000 -91.26%
on 09/19/18
-2.2994 (-71.86%)
since 09/14/18
3-Month
0.9000 +0.07%
on 10/15/18
10.3000 -91.26%
on 09/19/18
-1.8394 (-67.13%)
since 07/13/18
52-Week
0.9000 +0.07%
on 10/15/18
8,487.5000 -99.99%
on 10/19/17
-7,086.5996 (-99.99%)
since 10/13/17

Most Recent Stories

More News
CORRECTING and REPLACING - Delcath Expands Rollout of Registration Trial in Metastatic Ocular Melanoma

Seven Cancer Centers in United States Open for Enrollment in Amended Trial

DCTH : 0.9006 (-11.71%)
Liver Cancers Rising - Stocks to Watch

HENDERSON, NV / ACCESSWIRE / October 5, 2018 / Liver cancer incidence has more than tripled since 1980. Liver cancer death rates have increased by almost 3% per year since 2000. More than 700,000 people...

VKTX : 14.20 (-1.80%)
ENTA : 76.12 (+1.91%)
EXEL : 15.90 (-2.09%)
DCTH : 0.9006 (-11.71%)
Multi-center Analysis of Outcomes Data on Use of Delcath CHEMOSAT in the Treatment of ICC Published in European Radiology

Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that results of a multicenter analysis of outcomes...

DCTH : 0.9006 (-11.71%)
Medical Cannabis and Biotech Stocks to Watch

HENDERSON, NV / ACCESSWIRE / September 26, 2018 / Two of the most visible sectors on the market recently have been Medical Cannabis and Biotech, respectively. The demonstrated frequency of innovative breakthroughs...

ACBFF : 11.6800 (+11.03%)
APHQF : 15.3500 (+4.78%)
GWPH : 143.23 (-0.06%)
DCTH : 0.9006 (-11.71%)
Data from Prospective Phase 2 Study Investigating Delcath's PHP Therapy presented at CIRSE 2018

Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that results from a prospective study conducted...

DCTH : 0.9006 (-11.71%)
Intriguing Cannabis and Biotech Firms

HENDERSON, NV/ ACCESSWIRE / September 14, 2018 / A fascinating biotech firm DCTH (Delcath Systems, Inc.), has a very intriguing treatment for liver cancer. The company has initiated a global Phase 3 clinical...

CARA : 19.40 (+0.31%)
ACBFF : 11.6800 (+11.03%)
APHQF : 15.3500 (+4.78%)
INSY : 8.67 (-2.58%)
DCTH : 0.9006 (-11.71%)
Delcath Reminds Shareholders that the Rights Offering Subscription Period Expires Wednesday, September 26, 2018

Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, reminds its shareholders of the expiration on Wednesday September...

DCTH : 0.9006 (-11.71%)
Cannabis and Biotech Firms Uptrending

HENDERSON, NV / ACCESSWIRE / September 10, 2018 / A fascinating biotech firm DCTH (Delcath Systems, Inc.), has an intriguing treatment for liver cancer. The company has initiated a global Phase 3 clinical...

ACBFF : 11.6800 (+11.03%)
DCTH : 0.9006 (-11.71%)
Multi-center Analysis of Outcomes Data on Use of Delcath CHEMOSAT in the Treatment of ICC to be Published in European Radiology

Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the result of a multicenter analysis of outcomes...

DCTH : 0.9006 (-11.71%)
Delcath Announces Extension of Rights Offering Period to September 26, 2018

Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that it has completed the initial rights offering period...

DCTH : 0.9006 (-11.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade DCTH with:

Key Turning Points

2nd Resistance Point 1.1535
1st Resistance Point 1.0271
Last Price 0.9006
1st Support Level 0.8371
2nd Support Level 0.7735

See More

52-Week High 8,487.5000
Fibonacci 61.8% 5,245.6187
Fibonacci 50% 4,244.2002
Fibonacci 38.2% 3,242.7813
Last Price 0.9006
52-Week Low 0.9000

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar